Passiflora incarnata L.: Ethnopharmacology, clinical application, safety and evaluation of clinical trials

Journal of Ethnopharmacology

Volumn 150, Issue 3, 2013, Pages 791-804

  Miroddi, M ^a   Calapai, G ^a   Navarra, M ^b   Minciullo, P L ^a   Gangemi, S ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Anxiety; Insomnia; Passiflora incarnata; Sleep disorders

Indexed keywords

APIGENIN; BENZODIAZEPINE DERIVATIVE; CHRYSIN; DIAZEPAM; HARMAN; ISOORIENTIN; ISOVITEXIN; KAEMPFEROL; METHYLPHENIDATE; ORIENTIN; OXAZEPAM; PASSIFLORA INCARNATA EXTRACT; PLANT MEDICINAL PRODUCT; QUERCETIN; VITEXIN;

ANALGESIA; ANTINEOPLASTIC ACTIVITY; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BREAST CARCINOMA; BRONCHOSPASM; BURN; CLINICAL TRIAL (TOPIC); CONSTIPATION; COUGHING; DEPRESSION; DIARRHEA; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG INTOXICATION; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; DYSMENORRHEA; DYSPHORIA; EPILEPSY; ETHNOPHARMACOLOGY; FERTILITY; GENERALIZED ANXIETY DISORDER; HEART VENTRICLE TACHYCARDIA; HEMORRHOID; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; HYPNOSIS; HYSTERIA; INFECTION; INSOMNIA; MENOPAUSAL SYNDROME; MENTAL STRESS; MORPHINE ADDICTION; MUSCLE CRAMP; MUSCLE FATIGUE; NAUSEA; NEURASTHENIA; NEUROLOGIC DISEASE; NONHUMAN; OCCUPATIONAL ASTHMA; OPIATE ADDICTION; PASSIFLORA; PASSIFLORA INCARNATA; PHYTOTHERAPY; PREGNANCY; PREMENSTRUAL SYNDROME; PSYCHOSIS; QT PROLONGATION; REVIEW; RHINITIS; SEIZURE; SINGLE DRUG DOSE; SLEEP DISORDER; SLEEP TIME; SPERMATOZOON COUNT; STREPTOZOCIN DIABETES; SUICIDAL IDEATION; THIN LAYER CHROMATOGRAPHY; TOBACCO DEPENDENCE; TRADITIONAL MEDICINE; TRANQUILIZING ACTIVITY; VASOMOTOR DISORDER; VOMITING; WITHDRAWAL SYNDROME;

PASSIFLORA INCARNATA; PASSIFLORACEAE; SCOPUS;

ANXIETY; INSOMNIA; PASSIFLORA INCARNATA; SLEEP DISORDERS;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ETHNOPHARMACOLOGY; HUMANS; MENOPAUSE; OPIOID-RELATED DISORDERS; PASSIFLORA; PHYTOCHEMICALS; PLANT EXTRACTS; SLEEP DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84889091122     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.09.047     Document Type: Review

References (106)

1. E.A. Abourashed, J.R. Vanderplank, and I.A. Khan High-speed extraction and HPLC fingerprinting of medicinal plants-I. Application to Passiflora flavonoids Pharm. Biol. 40 2002 81 91 (Pubitemid 34765385)
2. S. Akhondzadeh, L. Kashani, M. Mobaseri, S. Hosseini, S. Nikzad, and M. Khani Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial J. Clin. Pharm. Ther. 26 2001 369 373 (Pubitemid 32989559)
3. S. Akhondzadeh, M. Mohammadi, and F. Momeni Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents Therapy 2 2005 609 614 (Pubitemid 41015142)
4. S. Akhondzadeh, H. Naghavi, M. Vazirian, A. Shayeganpour, H. Rashidi, and M. Khani Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam J. Clin. Pharm. Ther. 26 2001 363 367 (Pubitemid 32989558)
5. K. Appel, T. Rose, B. Fiebich, T. Kammler, C. Hoffmann, and G. Weiss Modulation of the gamma-aminobutyric acid (GABA) system by Passiflora incarnata L Phytother. Res. 25 2011 838 843
6. P. Aslanargun, O. Cuvas, B. Dikmen, E. Aslan, and M.U. Yuksel Passiflora incarnata Linneaus as an anxiolytic before spinal anaesthesia J. Anesth. 26 2012 39 44
7. American Psychiatric American Psychiatric Association VVAA, 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth ed. Arlington, USA.
8. L. Beverley The hystory and the present state of Virginia 1947 University of North Carolina press Chapel Hill
9. F.L. Bishop, and G. Lewith Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use Evidence-Based Complementary Altern. Med. 7 2010 11 28
10. C. Breivogel, and B. Jamerson Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats Pharm. Biol. 50 2012 1310 1316
11. P.R. Bradley British Herbal Compendium vol. 1 1992 British Herbal Medicine Association Bournemouth, UK
12. G.A. Burdock, and I.G. Carabin Generally recognized as safe (GRAS): history and description Toxicol. lett. 150 2004 3 18 (Pubitemid 38447232)
13. J. Bruneton Pharmacognosy, Phytochemistry, Medicinal Plants 1995 Lavoisier Publishing Paris
14. E.L. Campbell, M. Chebib, and G.A. Johnston The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A)receptors Biochem. Pharmacol. 68 2004 1631 1638 (Pubitemid 39286467)
15. A. Capasso, and L. Sorrentino Pharmacological studies on the sedative and hypnotic effect of Kava kava and Passiflora extracts combination Phytomedicen 12 2005 39 45 (Pubitemid 40174327)
16. M.C. Carrasco, J.R. Vallejo, M. Pardo-de-Santayana, D. Peral, M.Á. Martín, and J. Altimiras Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam Phytother. Res. 23 2008 1795 1796
17. B. Carratù, C. Boniglia, S. Giammarioli, M. Mosca, and E. Sanzini Free amino acids in botanicals and botanical preparations J. Food Sci. 73 2008 C323 C328
18. H.D. Clark, G.A. Wells, C. Huët, F.A. McAlister, L.R. Salmi, D. Fergusson, and A. Laupacis Assessing the quality of randomized trials: reliability of the Jadad scale Controlled Clin. Trials 20 1999 448 452 (Pubitemid 29460921)
19. K. Dhawan, S. Kumar, and A. Sharma Anti-anxiety studies on extracts of Passiflora incarnata Linneaus J. Ethnopharmacol. 78 2001 165 170 (Pubitemid 32994786)
20. K. Dhawan, S. Kumar, and A. Sharma Anxiolytic activity of aerial and underground parts of Passiflora incarnata Fitoterapia 72 2001 922 926 (Pubitemid 33122201)
21. K. Dhawan, S. Kumar, and A. Sharma Comparative biological activity study on Passiflora incarnata and Passiflora edulis Fitoterapia 72 2001 698 702 (Pubitemid 32799277)
22. K. Dhawan, S. Kumar, and A. Sharma Suppression of alcohol-cessation- oriented hyper-anxiety by the benzoflavone moiety of Passiflora incarnata Linneaus in mice J. Ethnopharmacol. 81 2002 239 244 (Pubitemid 34628508)
23. K. Dhawan, S. Kumar, and A. Sharma Reversal of cannabinoids (delta9THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction J. Pharm. Pharmacol. 54 2002 875 881 (Pubitemid 34649474)
24. K. Dhawan, S. Kumar, and A. Sharma Comparative anxiolytic activity profile of various preparations of Passiflora incarnata linneaus: a comment on medicinal plants' standardization J. Alternative Complementary Med. 8 2002 283 291 (Pubitemid 34753403)
25. K. Dhawan, and A. Sharma Prevention of chronic alcohol and nicotine-induced azospermia, sterility and decreased libido, by a novel tri-substituted benzoflavone moiety from Passiflora incarnata Linneaus in healthy male rats Life sci. 71 2002 3059 3069 (Pubitemid 35291079)
26. K. Dhawan, S. Kumar, and A. Sharma Reversal of morphine tolerance and dependence by Passiflora incarnata. A traditional medicine to combat morphine addiction Pharm. Biol. 40 2002 576 580 (Pubitemid 36238057)
27. K. Dhawan, and A. Sharma Antitussive activity of the methanol extract of Passiflora incarnata leaves Fitoterapia 73 2002 397 399 (Pubitemid 34879822)
28. K. Dhawan, S. Kumar, and A. Sharma Aphrodisiac activity of methanol extract of leaves of Passiflora incarnata Linn. in mice Phytother. Res. 17 2003 401 403 (Pubitemid 36565350)
29. K. Dhawan Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn.‚ a brief perspective Addict. Biol. 8 2003 379 386 (Pubitemid 38102044)
30. K. Dhawan, S. Dhawan, and S. Chhabra Attenuation of benzodiazepine dependence in mice by a tri-substituted benzoflavone moiety of Passiflora incarnata Linneaus: a non-habit forming anxiolytic J. Pharmacy Pharm. Sci. 6 2003 215 222 (Pubitemid 37207227)
31. K. Dhawan, S. Kumar, and A. Sharma Antiasthmatic activity of the methanol extract of leaves of Passiflora incarnata Phytothe. Res. 17 2003 821 822 (Pubitemid 37012270)
32. K. Dhawan, S. Kumar, and A. Sharma Evaluation of central nervous system effects of Passiflora incarnata in experimental animals Pharm. Biol. 41 2003 87 91 (Pubitemid 36776085)
33. Dhawan, K.; Sharma, A. 2003f. Restoration of chronic-Delta 9-THC-induced decline in sexuality in male rats by a novel benzoflavone moiety from Passiflora incarnata Linn. Br. J. Pharmacol. Jan;138:117-120. (Pubitemid 36194210)
34. K. Dhawan, S. Dhawan, and A. Sharma Passiflora: a review update J. Ethnopharmacol. 94 2004 1
35. S.M. Elsas, D. Rossi, J. Raber, G. White, C.A. Seeley, and W. Gregory Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method Phytomed.: Int. J. Phytother. Phytopharm. 17 2010 940
36. EMA 2008. Committee on Herbal Medicinal Products (HMPC) PASSIFLORA INCARNATA L.; Herba Passion Flower EMA/HMPC/218548/2008 Assessment Report.
37. ESCOP 'Passiflorae herba.' Monographs on the Medicinal Uses of Plant Drugs 1997 European Scientific Cooperative on Phytotherapy Exeter, UK
38. ESCOP Passiflorae herba. Monographs 2nd ed. 2007 European Scientific Cooperative on Phytotherapy Exeter, UK
39. European Pharmacopoeia 7th edition. 2010. Council of Europe, Strasbourg.
40. F. Fahami, Z. Asali, A. Aslani, and N. Fathizadeh A comparative study on the effects of hypericum perforatum and passion flower on the menopausal symptoms of women referring to Isfahan city health care centers Iran. J. Nurs. Midwifery Res. 15 2010 202
41. Finniss, D.G.; Kaptchuk T.J.; Miller F.; Benedetti F.; 2010. Biological, clinical, and ethical advances of placebo effects. Lancet, 20;375(9715), 686-95.
42. A.A. Fisher, P. Purcell, and D.G. Le Couteur Toxicity of Passiflora incarnata L Clin. Toxicol. 38 2000 63 66
43. E.W. Freeman, M.D. Sammel, H. Lin, Z. Liu, and C.R. Gracia Duration of menopausal hot flushes and associated risk factors Obstet. Gynecol. 5 2011 1095
44. M. Frass, R.P. Strassl, H. Friehs, M. Moellner, M. Kundi, and A.D. Kaye Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review Ochsner J. 12 2012 45 56
45. J.J. Gagnier, H. Boon, P. Rochon, D. Moher, J. Barnes, and C. Bombardier Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement Ann. Internal Med. 144 2006 364 367 (Pubitemid 46768190)
46. P.F. Giavina-Bianchi Jr, F.F. Castro, M.L.S. Machado, and A.J. Duarte Occupational Respiratory Allergic Disease Induced by Passiflora alata and Rhamnus purshiana Ann. Allergy, Asthma Immunol. 79 1997 449 454 (Pubitemid 27514972)
47. K.J. Gremillion The development of a mutualistic relationship between humans and maypops (Passiflora incarnata L.) in the southeastern United States J. Ethnobiol. 9 1989 135 155
48. O. Grundmann, C. Wahling, C. Staiger, and V. Butterweck Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice Die Pharmazie-An Int. J. Pharm. Sci. 64 2009 63 64
49. O. Grundmann, J. Wang, G.P. McGregor, and V. Butterweck Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system Planta Med. 74 2008 1769 1773
50. R.K. Gupta, D. Kumar, A.K. Chaudhary, M. Maithani, and R. Singh Antidiabetic activity of Passiflora incarnata Linn. in streptozotocin-induced diabetes in mice J. Ethnopharmacol. 139 2012 801 806
51. M. Holbik, S. Krasteva, N. Mayer, H. Kählig, and L. Krenn Apparently no sedative benzoflavone moiety in passiflorae herba Planta Med. 76 2010 662 664
52. H. Hoppe Drogenkunde 1958 Cram, De Gruuyter & Co. Hamburg, Germany
53. A. Ingale, and A. Hivrale Pharmacological studies of Passiflora sp. and their bioactive compounds Afr. J. Plant Sci. 4 2010 417 426
54. M.M. Iwu Ethnobotanical approach to pharmaceutical drug discovery: strengths and limitations Adv. Phytomed. 1 2002 309 320
55. J.P. Kelly, D.W. Kaufman, K. Kelley, L. Rosenberg, T.E. Anderson, and A.A. Mitchell Recent trends in use of herbal and other natural products Arch. Internal Med. 165 2005 281
56. R.C. Kessler, A.M. Ruscio, K. Shear, and H-U. Wittchen Epidemiology of anxiety disorders. Behavioral neurobiology of anxiety and its treatment 2010 Springer, Berlin 21 35
57. G. Kinghorn Passion, stigma, and STI Sexually Transmitted Infections 77 2001 370 375 (Pubitemid 32964275)
58. N. Koen, and D.J. Stein Pharmacotherapy of anxiety disorders: a critical review Dialogues in Clin. Neurosci. 13 2011 423
59. L. Krenn Passion Flower (Passiflora incarnata L.)-a reliable herbal sedative Wien. Med. Wochenschr. 152 15-16 2001 404 406
60. P.H. List, and L. Hörhammer Hagers Handbuch Ed. 1977 Springer Verlag Berlin, Germany
61. J. Lutomski, E. Segiet, K. Szpunar, and K. Grisse [The importance of the passionflower in medicine] Pharm. Unserer Zeit 10 1981 45
62. G. Madaus Lehrbuch der biologischen Heilmittel 1938 Georg Thieme Verlag Leipzig, Germany
63. E. Marchart, L. Krenn, and B. Kopp Quantification of the flavonoid glycosides in Passiflora incarnata by capillary electrophoresis Planta Med. 69 2003 452 466
64. J.H. Medina, A.C. Paladini, C. Wolfman, M.L. de Stein, D. Calvo, L.E. Diaz, and C. Peña Chrysin (5, 7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties Biochem. Pharmacol. 40 1990 2227 2231 (Pubitemid 20373980)
65. Miyasaka L.; Atallah A.; Soares B.; 2007. Passiflora for anxiety disorder Cochrane Database Systematic Review. 1.
66. Miroddi, M.; Mannucci, C.; Mancari, F.; Navarra, M.; Calapai, G.; 2013. Research and development for botanical products in medicinals and food supplements market. Evid. Based Complement. Alternat. Med. 2013:649720.
67. A. Movafegh, R. Alizadeh, F. Hajimohamadi, F. Esfehani, and M. Nejatfar Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study Anesth. Analg. 106 2008 1728 1732
68. M. Nassiri-Asl, S. Shariati-Rad, and F. Zamansoltani Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors BMC Complementary Alternative Med. 7 2007 26
69. H.D. Neuwinger African Traditional Medicine: a Dictionary of Plant Use and Applications 2000 With Supplement: Search System for Diseases: Medpharm Stuttgart, Germany
70. C.A. Newall, L.A. Anderson, and J.D. Phillipson Herbal Medicines: A Guide for Health-Care Professionals 1996 The Pharmaceutical Press London, U.K.
71. A Ngan, and R. Conduit A Double-blind, placebo controlled investigation of the effects of Passiflora incarnata (Passionflower) herbal tea on subjective sleep quality Phytother. Res. 25 2011 1153 1159
72. C.A. Pereira, J.H. Yariwake, F.M. Lanças, J.N. Wauters, M. Tits, and L. Angenot A HPTLC densitometric determination of flavonoids from Passiflora alata, Passiflora edulis, Passiflora incarnata and P. caerulea and comparison with HPLC method Phytochem. Analisis 15 2004 241 248 (Pubitemid 39136525)
73. W. Poethke, C. Schwarz, and H. Gerlach Contents of Passiflora bryonioides. 1. Alkaloids Planta Med. 18 1970 303
74. L. Qimin, H. Van den Heuvel, and O. Delorenzo Mass spectral characterization of C-glycosidic flavonoids isolated from a medicinal plant (Passiflora incarnata) J. Chromatogr. B: Biomed. Sci. Appl. 562 1991 435 446
75. A. Raffaelli, G. Moneti, V. Mercati, and E. Toja Mass spectrometric characterization of flavonoids in extracts from Passiflora incarnata J. Chromatogr. 777 1997 223 231 (Pubitemid 27353344)
76. C. Ratsch The Encyclopedia of Psychoactive Plants: Ethnopharmacology and its Applications 1998 Park Street Press Rochester, U.S.A
77. A. Rehwald, O. Sticher, and B. Meier Trace analysis of harman alkaloids in Passiflora incarnata by reversed-phase high performance liquid chromatography Phytochem. Analysis 6 1995 96 100 (Pubitemid 26124096)
78. L. Rodriguez-Fragoso, J. Reyes-Esparza, S.W. Burchiel, D. Herrera-Ruiz, and E. Torres Risks and benefits of commonly used herbal medicines in Mexico Toxicol. Appl. Pharmacol. 227 2008 125 135 (Pubitemid 351179848)
79. C. Sampath, M. Holbik, L. Krenn, and V. Butterweck Anxiolytic effects of fractions obtained from Passiflora incarnata L. in the elevated plus maze in mice Phytother. Res. 25 2011 789 795
80. H. Schulz, M. Jobert, and W. Hübner The quantitative EEG as a screening instrument to identify sedative effects of single doses of plant extracts in comparison with diazepam Phytomedicine 5 1998 449 458 (Pubitemid 128786128)
81. M. Shaw, P. Hodgkins, H. Caci, S. Young, J. Kahle, A.G. Woods, and L.E. Arnold A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment BMC Med. 101 2012 99
82. K. Shinomiya, T. Inoue, Y. Utsu, S. Tokunaga, T. Masuoka, A. Ohmori, and C. Kamei Hypnotic activities of chamomile and passiflora extracts in sleep-disturbed rats Biolo. Pharm. Bull. 28 2005 808 810 (Pubitemid 40740645)
83. B. Singh, D. Singh, and R.K. Goel Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression J. Ethnopharmacol. 139 2012 273 279
84. G. Smith, T. Chalmers, and G. Nuki Vasculitis associated with herbal preparation containing passiflora extract Rheumatology 32 1993 87 88 (Pubitemid 23053608)
85. R. Soulimani, C. Younos, S. Jarmouni, D. Bousta, R. Misslin, and F. Mortier Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse J. Ethnopharmacol. 57 1997 11 20 (Pubitemid 27303468)
86. K.C. Spencer, and D.S. Seigler Passibiflorin, epipassibiflorin and passitrifasciatin: cyclopentenoid cyanogenic glycosides from Passiflora Phytochemistry 24 1985 981 986
87. E. Speroni, and A. Minghetti Neuropharmacological activity of extracts from Passiflora incarnata Planta Med. 54 2007 488 491
88. A.P. Spira, L. Friedman, J.S. Aulakh, T. Lee, J.I. Sheikh, and J.A. Yesavage Subclinical anxiety symptoms, sleep, and daytime dysfunction in older adults with primary insomnia J. Geriatr. Psychiatry Neurol. 21 2008 149 153
89. V.I Spoormaker, and J. van den Bout Depression and anxiety; relations with sleep disturbances Euro. Psychiatry 20 2005 243 245 (Pubitemid 40779634)
90. L. Taylor Maracuja Herbal Secrets of the Rainforest 1996 Prime publishing inc Austin
91. T. Ulmer, J.M. MacDougal, and B. Ulmer Passiflora: passionflowers of the world 2004 Timber Press Portland, USA
92. VA.1978. Deutsches Homopathisches Arzneibuch, 1st ed. Deutscher Apotheker Verlag, Stuttgart, Germany.
93. VA. 1987. Pharmacopoeia Helvetica, 7th ed. vol. 14.(Ph.Helv.VII). Office Central Fdral des Imprims et du Matriel, Bern, Swiss.
94. VA The Homeopathic Pharmacopoeia of the United States (HPUS) 1992 Pharmacopoeia Convention of the American Institute of Homeopathy Arlington, USA
95. VA Deutsches Arzneibuch 1997 Deutscher Apotheker Verlag Stuttgart, Germany
96. VA British Herbal Pharmacopoeia (BHP) 1996 British Herbal Medicine Association Exeter, UK
97. K. Vesco, E. Haney, L. Humphrey, R. Fu, and H. Nelson Influence of menopause on mood: a systematic review of cohort studies Climacteric 10 2007 448 465 (Pubitemid 350211296)
98. H. Wohlmuth, K.G. Penman, T. Pearson, and R.P. Lehmann Pharmacognosy and chemotypes of passionflower (Passiflora incarnata L.) Biolo. Pharm. Bull. 33 2010 1015 1018
99. R. Yockteng, G.C. d'Eeckenbrugge, and T.T. Souza-Chies Passiflora. Wild Crop Relatives: Genomic and Breeding Resources 2011 Springer Berlin 129 171
100. Van Dan N.; Chuong B.X.; 1990. Medicinal Plants in Viet Nam: World Health Organization Regional Office for the Western Pacific.
101. C. Vissiennon, K. Nieber, O. Kelber, and V. Butterweck Route of administration determines the anxiolytic activity of the flavonols kaempferol, quercetin and myricetin-are they prodrugs? J. Nutr. Biochem. 23 2012 733 740
102. V.J. Vogel American Indian influence on the American pharmacopeia Am. Indian Culture Res. J. 2 1977 3 7
103. www.plantlist.org, 2012. A working list of all plant species. (accessed December 2013)
104. P. Zanoli, R. Avallone, and M. Baraldi Behavioral characterisation of the flavonoids apigenin and chrysin Fitoterapia 71 2000 117 123
105. Y. Zhou, F. Tan, and J. Deng [Update review of Passiflora] China J. Chin. Materia Medica 33 2008 1789
106. S.M. Zucolotto, C. Fagundes, F.H. Reginatto, F.A. Ramos, L. Castellanos, C. Duque, and E.P. Schenkel Analysis of C-glycosyl Flavonoids from South American Passiflora Species by HPLC-DAD and HPLC-MS Phytochem. Anal. 23 2012 232 239